Luoyang zhonghe hospital research base

Luoyang Zhonghe Hospital is the seat of Li Kang Institute of Cerebrovascular Diseases in Luoyang. It is a first-class cerebrovascular disease research and treatment center integrating medical treatment, scientific research, teaching, first aid, rehabilitation and prevention. There are 4 professors, senior engineers, 2 doctoral students and 6 master students in the hospital, and 80% of them have bachelor degree or above. Luoyang Zhonghe Hospital is not only the transformation base of cerebrovascular disease research results, but also the highlight of clinical research and exploration and treatment of other nervous system diseases. The main research direction of Li Kang Institute of Cerebrovascular Diseases is to carry out theoretical and practical research and development of neurology, neurosurgery and ultrasonic treatment of transcranial cerebrovascular diseases.

Rehabilitation therapy with advanced characteristics

The hospital is equipped with 800 square meters of the city's most advanced encephalopathy rehabilitation center, equipped with the most advanced transcranial ultrasound therapeutic instrument and corresponding encephalopathy rehabilitation technology.

Transcranial ultrasound thrombolytic therapy instrument is characterized by using the images of skull CT or nuclear magnetic resonance, and using the national patent number brain focus locator (200720090983.8) to find the best treatment site of intracranial lesions on the brain surface. Then ultrasound thrombolysis was performed. During the treatment, the patient has no pain and any discomfort. In order to improve the effect of ultrasound therapy, music and voice prompts are provided to make patients focus on ultrasound therapy, relax and improve the blood supply to the brain.

Indications of transcranial ultrasound thrombolytic therapy instrument: 1. Early treatment of cerebral infarction: The use of transcranial ultrasound thrombolytic therapy instrument alone can dissolve cerebral thrombosis, which is not limited by thrombolytic time window. Recirculate blocked cerebral vessels. If combined with rt-PA or urokinase, it can improve the thrombolytic effect of enzymatic thrombolytic drugs and reduce the complications of cerebral hemorrhage. 2. Treatment of cerebral infarction, cerebral hemorrhage and brain injury in recovery period. Transcranial ultrasound therapy can dilate cerebral vessels, improve cerebral blood circulation, promote the establishment of lateral lipid circulation, improve the metabolic level of brain cells, improve "semi-dark" blood supply, and restore the function of ischemic and hypoxic brain cells. The clinical manifestations are the recovery and improvement of paralyzed limbs and language functions. The combination of brain ultrasound therapy and limb rehabilitation training can obviously improve the therapeutic effect. 3. Treatment of cerebral arteriosclerosis and cerebrovascular stenosis: For patients with abnormal cerebral vessels examined by transcranial Doppler, transcranial ultrasound can dilate the narrowed cerebral vessels, promote the establishment of collateral circulation, improve the blood circulation in the ischemic area, reduce or disappear TIA (transient ischemic attack), and prevent the occurrence of cerebral infarction.

On the basis of treating cerebrovascular diseases, transcranial ultrasound has expanded its treatment scope to Parkinson's disease, epilepsy, encephalopathy after carbon monoxide poisoning, brain injury recovery, Alzheimer's disease, insomnia and so on, and achieved certain curative effects.